IFIH1 and dermatomyositis: By contrast, a severe ILD, named rapidly progressive ILD (RPILD), was described, especially in Asian cohorts, in hypo- or amyopathic dermatomyositis (DM), associated with anti-MDA-5 antibodies, characterized by a rapid decline of functional status and a high mortality rate [6–11].